Luye Pharma Group Releases Clinical Trial Results

February 15, 2022

Luye Pharma Group recently released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005), at the 19th National Psychiatry Conference.....

Subscribe for Full Access!

Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!

Subscribe!

Key Data Topics Luye Pharma, pharmaceutical

Share this Data

Other Sourcing Intelligence

Journey of the Millennium Babies of Africa: Insights Revealed

October 23, 2025

China-US Trade Talks Set to Influence Global Markets

October 23, 2025

US Plans Further Restrictions on Critical Software Exports to China Amid Escalating Trade Tensions

October 23, 2025

China's Standoff with U.S. Threatens Key Summit: Trade Tensions Mount

October 23, 2025

Escalating Trade Tensions: U.S. Considers New Export Controls on China

October 23, 2025

Sunrise Breakthrough in AI-Driven Technology Redefines Manufacturing Standards for Graphite Micro-Powder Production

October 23, 2025